Growth Metrics

SELLAS Life Sciences Group (SLS) Current Assets: 2011-2023

Historic Current Assets for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $3.2 million.

  • SELLAS Life Sciences Group's Current Assets rose 361.95% to $24.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.0 million, marking a year-over-year increase of 361.95%. This contributed to the annual value of $3.2 million for FY2023, which is 82.14% down from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Current Assets stood at $3.2 million for FY2023, which was down 82.14% from $17.8 million recorded in FY2022.
  • Over the past 5 years, SELLAS Life Sciences Group's Current Assets peaked at $36.9 million during FY2020, and registered a low of $3.2 million during FY2023.
  • For the 3-year period, SELLAS Life Sciences Group's Current Assets averaged around $14.7 million, with its median value being $17.8 million (2022).
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 348.01% in 2020, then plummeted by 82.14% in 2023.
  • Over the past 5 years, SELLAS Life Sciences Group's Current Assets (Yearly) stood at $8.2 million in 2019, then spiked by 348.01% to $36.9 million in 2020, then slumped by 37.59% to $23.0 million in 2021, then fell by 22.95% to $17.8 million in 2022, then plummeted by 82.14% to $3.2 million in 2023.